Terms: = Ovarian cancer AND ELK4, SAP1, 2005, ENSG00000158711, P28324 AND Prognosis
116 results:
1. Agricultural exposure and risk of ovarian cancer in the AGRIculture and cancer (AGRICAN) cohort.
Renier M; Hippert J; Louis-Bastien W; Tual S; Meryet-Figuiere M; Vigneron N; Marcotullio E; Baldi I; Lebailly P;
Occup Environ Med; 2024 Feb; 81(2):75-83. PubMed ID: 38199811
[TBL] [Abstract] [Full Text] [Related]
2. Prognostic factors of patients with recurrent uterine malignancies undergoing secondary cytoreductive surgery.
Fang C; Zhang Y; Zhang P; Zhu T
BMC Womens Health; 2024 Jan; 24(1):9. PubMed ID: 38166810
[TBL] [Abstract] [Full Text] [Related]
3. Impact of multimorbidity and polypharmacy on mortality after cancer: a nationwide registry-based cohort study in Denmark 2005-2017.
Thomsen MK; Løppenthin KB; Bidstrup PE; Andersen EW; Dalton S; Petersen LN; Pappot H; Mortensen CE; Christensen MB; Frølich A; Lassen U; Johansen C
Acta Oncol; 2023 Dec; 62(12):1653-1660. PubMed ID: 37874076
[TBL] [Abstract] [Full Text] [Related]
4. High serum levels of inflammatory markers are associated with early recurrence in patients with high-grade serous ovarian cancer after platinum therapy.
Brzezinska B; Mysona DP; Richardson KP; Rungruang B; Hopkins D; Bearden G; Higgins R; Johnson M; Satter KB; McIndoe R; Ghamande S; Purohit S
Gynecol Oncol; 2023 Dec; 179():1-8. PubMed ID: 37862814
[TBL] [Abstract] [Full Text] [Related]
5. Prognostic impact of molecular profiles and molecular signatures in clear cell ovarian cancer.
Schnack TH; Oliveira DNP; Christiansen AP; Høgdall C; Høgdall E
Cancer Genet; 2023 Nov; 278-279():9-16. PubMed ID: 37567101
[TBL] [Abstract] [Full Text] [Related]
6. Genetic analysis for mucinous ovarian carcinoma with infiltrative and expansile invasion and mucinous borderline tumor: a retrospective analysis.
Hada T; Miyamoto M; Ohtsuka Y; Suminokura J; Ito T; Kishimoto N; Nishitani S; Takada M; Imauji A; Tanabe R; Takano M
Diagn Pathol; 2023 Apr; 18(1):49. PubMed ID: 37081552
[TBL] [Abstract] [Full Text] [Related]
7. ovarian cancer prevention by opportunistic salpingectomy is a new de facto standard in Germany.
Runnebaum IB; Kather A; Vorwergk J; Cruz JJ; Mothes AR; Beteta CR; Boer J; Keller M; Pölcher M; Mustea A; Sehouli J
J Cancer Res Clin Oncol; 2023 Aug; 149(10):6953-6966. PubMed ID: 36847838
[TBL] [Abstract] [Full Text] [Related]
8. Clinical calculator redefines prognosis for high-risk early-stage ovarian cancers and potential to guide treatment in the adjuvant setting.
Bui A; Gehrig PA; Ghamande S; Rungruang BJ; Chan JK; Mysona DP
Gynecol Oncol; 2022 Nov; 167(2):205-212. PubMed ID: 36055814
[TBL] [Abstract] [Full Text] [Related]
9. [Clinicopathological features of malignant mixed mesodermal tumor: analysis of 50 cases].
Ding XH; Ma ZY; Wang YF; Dou FX; Yuan J; Tian X; Liu AJ
Zhonghua Bing Li Xue Za Zhi; 2021 Sep; 50(9):1008-1013. PubMed ID: 34496490
[No Abstract] [Full Text] [Related]
10. The use of bevacizumab is correlated with improved post-progression survival in advanced recurrent ovarian cancer.
Yanazume S; Ushiwaka T; Fukuda M; Togami S; Kamio M; Kobayashi H
Jpn J Clin Oncol; 2021 Aug; 51(9):1407-1415. PubMed ID: 34240168
[TBL] [Abstract] [Full Text] [Related]
11. What can we learn from the 10 mm lymph node size cut-off on the CT in advanced ovarian cancer at the time of interval debulking surgery?
Benoit L; Zerbib J; Koual M; Nguyen-Xuan HT; Delanoy N; Le Frère-Belda MA; Bentivegna E; Bats AS; Fournier L; Azaïs H
Gynecol Oncol; 2021 Sep; 162(3):667-673. PubMed ID: 34217542
[TBL] [Abstract] [Full Text] [Related]
12. ovarian cancer population screening and mortality after long-term follow-up in the UK Collaborative Trial of ovarian cancer Screening (UKCTOCS): a randomised controlled trial.
Menon U; Gentry-Maharaj A; Burnell M; Singh N; Ryan A; Karpinskyj C; Carlino G; Taylor J; Massingham SK; Raikou M; Kalsi JK; Woolas R; Manchanda R; Arora R; Casey L; Dawnay A; Dobbs S; Leeson S; Mould T; Seif MW; Sharma A; Williamson K; Liu Y; Fallowfield L; McGuire AJ; Campbell S; Skates SJ; Jacobs IJ; Parmar M
Lancet; 2021 Jun; 397(10290):2182-2193. PubMed ID: 33991479
[TBL] [Abstract] [Full Text] [Related]
13. ovarian metastasis from nongynecologic primary sites: a retrospective analysis of 177 cases and 13-year experience.
Zhang JJ; Cao DY; Yang JX; Shen K
J Ovarian Res; 2020 Oct; 13(1):128. PubMed ID: 33109236
[TBL] [Abstract] [Full Text] [Related]
14. Oncological and Reproductive Outcomes of Fertility-sparing Surgery in Women with Early-stage Epithelial ovarian Carcinoma: A Multicenter Retrospective Study.
Chen J; Wang FF; Zhang Y; Yang B; Ai JH; Wang XY; Cheng XD; Li KZ
Curr Med Sci; 2020 Aug; 40(4):745-752. PubMed ID: 32862386
[TBL] [Abstract] [Full Text] [Related]
15. ovarian cancer symptoms, routes to diagnosis and survival - Population cohort study in the 'no screen' arm of the UK Collaborative Trial of ovarian cancer Screening (UKCTOCS).
Dilley J; Burnell M; Gentry-Maharaj A; Ryan A; Neophytou C; Apostolidou S; Karpinskyj C; Kalsi J; Mould T; Woolas R; Singh N; Widschwendter M; Fallowfield L; Campbell S; Skates SJ; McGuire A; Parmar M; Jacobs I; Menon U
Gynecol Oncol; 2020 Aug; 158(2):316-322. PubMed ID: 32561125
[TBL] [Abstract] [Full Text] [Related]
16. Metastatic patterns do not provide additional prognostic information for patients with FIGO stage IV high-grade serous ovarian cancer.
Feng Z; Wen H; Ju X; Bi R; Chen X; Yang W; Wu X
J Surg Oncol; 2020 Aug; 122(2):315-319. PubMed ID: 32500598
[TBL] [Abstract] [Full Text] [Related]
17. The Preoperative Prognostic Nutritional Index for the Prediction of Outcomes in Patients with Early-Stage ovarian Clear Cell Carcinoma.
Yoshikawa N; Yoshida K; Tamauchi S; Ikeda Y; Nishino K; Niimi K; Suzuki S; Kikkawa F; Kajiyama H
Sci Rep; 2020 Apr; 10(1):7135. PubMed ID: 32346076
[TBL] [Abstract] [Full Text] [Related]
18. Risk factors for early death among ovarian cancer patients: a nationwide cohort study.
Mosgaard BJ; Meaidi A; Høgdall C; Noer MC
J Gynecol Oncol; 2020 May; 31(3):e30. PubMed ID: 32026656
[TBL] [Abstract] [Full Text] [Related]
19. Prognostic value of neutrophil-to-lymphocyte ratio in early-stage ovarian clear-cell carcinoma.
Yoshida K; Yoshikawa N; Shirakawa A; Niimi K; Suzuki S; Kajiyama H; Kikkawa F
J Gynecol Oncol; 2019 Nov; 30(6):e85. PubMed ID: 31576683
[TBL] [Abstract] [Full Text] [Related]
20. Prediagnostic Proinflammatory Dietary Potential Is Associated with All-Cause Mortality among African-American Women with High-Grade Serous ovarian Carcinoma.
Peres LC; Hebert JR; Qin B; Guertin KA; Bandera EV; Shivappa N; Camacho TF; Chyn D; Alberg AJ; Barnholtz-Sloan JS; Bondy ML; Cote ML; Funkhouser E; Moorman PG; Peters ES; Schwartz AG; Terry PD; Schildkraut JM
J Nutr; 2019 Sep; 149(9):1606-1616. PubMed ID: 31152675
[TBL] [Abstract] [Full Text] [Related]
[Next]
